Product Reports Resources Pricing Login Book a demo

Outer Biosciences

Health · Palo Alto, United States · Founded 2020

AI-driven bioactive discovery using long-lasting skin models. MoreLess

Outer Biosciences, also known as Outer Bio, is a biotechnology research company that develops novel bioactive compounds for the health and beauty industries. Founded in 2020 by a team including CEO Michael Polansky, Chief Scientist Kyung-Jin Jang, CTO Chris Hinojosa, and Chief Business Officer Stanley King, the company operates at the intersection of biology, artificial intelligence, and dermatology. Entertainer and entrepreneur Stefani Germanotta (Lady Gaga) also co-founded the company and serves on its board of directors. The company's core technology is its proprietary "Yuna" platform, which maintains full-thickness human skin tissue, sourced ethically from surgical discards, viable in a lab for up to a month. This extended timeframe allows researchers to observe complex biological processes such as collagen remodeling, pigmentation changes, and skin barrier repair, which are not observable in conventional, shorter-duration lab models. Outer Biosciences couples these advanced ex vivo skin models with an AI and machine learning platform. The AI models screen millions of compounds to predict which bioactives may safely produce desired results, and these predictions are then tested on the living skin samples. The resulting data, whether the test is successful or not, is fed back into the system, creating a powerful feedback loop that continually refines future predictions. The firm's business model is not to create a consumer-facing brand, but to operate as a research and development engine for the broader cosmetics and pharmaceutical industries. It aims to license or sell its validated, high-efficacy ingredients to other companies, which will then incorporate them into final products like serums and creams. One of its known partners is Lady Gaga's cosmetics brand, Haus Labs. As of late 2026, the company, based near Cambridge, Massachusetts, has raised approximately $23 million in funding from investors including Wing Venture Capital, Initialized Capital, and Sozo Ventures to scale its operations. Keywords: bioactive discovery, skin health, ex vivo skin models, artificial intelligence, machine learning, dermatology, cosmetics ingredients, tissue engineering, multimodal data analysis, preclinical development, Yuna platform, Michael Polansky, Lady Gaga, natural compounds, skincare research, organotypic models, high-throughput screening, computational biology, drug discovery, beauty technology, biotechnology

Company overview

Outer Biosciences company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2020
Headquarters
Palo Alto, United States
Employees
24
Open positions
None listed
Dealroom signal
90.4
client focusb2btechnologyArtificial IntelligencetechnologyMachine Learningbusiness modelManufacturingindustryHealthsectorBiotechnologysectorSkin CaresectorHealth and BeautysectorMedical & HealthcaresectorDermatologysectorCore AIsectorBiotech and PharmasectorWoman FoundersectorLongevity

Valuation & funding

Outer Biosciences funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCEquity / VC Aug 2026 $19M $76M Undisclosed
EARLY VCEquity / VC Apr 2022 $4M $16M Undisclosed
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 24
2025 19
2024 11
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Outer Biosciences website traffic

Latest recorded traffic for Outer Biosciences is 1.3K monthly website visits, down 18.8% over the last three months. Outer Biosciences's team grew 26.3% over the past year.

Latest monthly visits1.3K 3-month web change-18.8% 1-year team growth+26.3%
Monthly website visits27 observations · Jan 2023–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Outer Biosciences compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Outer Biosciences's talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on Outer Biosciences's cap table

Sourced from Dealroom's funding and investor records.

Other known 2 additional known investors
Brighter Capital
Hawktail

Global footprint

Where Outer Biosciences has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States95%
🇨🇦 Canada5%
2 countries shown

In the news

Latest news about Outer Biosciences

Recent press, funding announcements, and product moves mentioning Outer Biosciences — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Outer Biosciences

An AI-synthesized read of the highest-engagement posts about Outer Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Outer Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.